fda approval of tirzepatide for weight loss The popular medication MOUNJARO which has been used off label loss, is now APPROVED for weight loss. The same active ingredient is now being sold as ZEPBOUND if used FDA approves weight-loss drug Zepbound

Generalizability Concerns Most clinical trials have been conducted in specialized research settings with intensive monitoring and support

Practice stress management techniques, such as mindfulness, meditation, or yoga, to reduce stress and improve mental health

Nausea, vomiting, diarrhea, or reduced fluid intake can contribute to dehydration, which can cause fatigue and dizziness

There were no significant differences for any of the appetite, satiety or taste questions between the three medications

It is more common in women, but tends to be more severe and peaks later in men

It's being organized by ALIGN33 Media, founded by a filmmaker with lived experience of an eating disorder, who is building a national platform focused on transforming how eating disorders are understood, treated, funded, and prevented